Abstrato

The effect of surgical technique on quality of life in patients with pleural malignant mesothelioma.

Oliver Evans

Past asbestos exposure, either in the environment or at work, is frequently linked to Malignant Pleural Mesothelioma (MPM). Despite a range of multi-modal treatments such as tyrosinekinase inhibitors, surgery and radiation, and platinum-based chemotherapy, the average survival diagnosis for individuals with MPM is about 15 months. Many immunotherapies are being evaluated for use, but more research is needed to determine their efficacy. Most patients receive palliative care because they are at an advanced stage of the disease and have multiple comorbidities that preclude aggressive therapy from being used. As a short life is expected from the moment of diagnosis, the major objective of treatment is to control symptoms and improve the quality of life for these patients.